Investor’s Business Daily has suggested today that California-based biotech Gilead could merge with a competitor of comparable size, the most likely companies being Vertex Pharmaceuticals and Pfizer.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,